BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 29311580)

  • 21. Similarity in gene-regulatory networks suggests that cancer cells share characteristics of embryonic neural cells.
    Zhang Z; Lei A; Xu L; Chen L; Chen Y; Zhang X; Gao Y; Yang X; Zhang M; Cao Y
    J Biol Chem; 2017 Aug; 292(31):12842-12859. PubMed ID: 28634230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene.
    Ambrosio S; Amente S; Saccà CD; Capasso M; Calogero RA; Lania L; Majello B
    Oncotarget; 2017 Jan; 8(3):3854-3869. PubMed ID: 27894074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LSD1 binds to HPV16 E7 and promotes the epithelial-mesenchymal transition in cervical cancer by demethylating histones at the Vimentin promoter.
    Liu Y; Wang Y; Chen C; Zhang J; Qian W; Dong Y; Liu Z; Zhang X; Wang X; Zhang Z; Shi X; Wu S
    Oncotarget; 2017 Feb; 8(7):11329-11342. PubMed ID: 27894088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
    Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
    Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone demethylase PHF8 promotes epithelial to mesenchymal transition and breast tumorigenesis.
    Shao P; Liu Q; Maina PK; Cui J; Bair TB; Li T; Umesalma S; Zhang W; Qi HH
    Nucleic Acids Res; 2017 Feb; 45(4):1687-1702. PubMed ID: 27899639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E239K mutation abolishes the suppressive effects of lysine-specific demethylase 1 on migration and invasion of MCF7 cells.
    Zhang Y; Wu T; Zhao B; Liu Z; Qian R; Zhang J; Shi Y; Wan Y; Li Z; Hu X
    Cancer Sci; 2022 Feb; 113(2):489-499. PubMed ID: 34839571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The histone LSD1 demethylase in stemness and cancer transcription programs.
    Amente S; Lania L; Majello B
    Biochim Biophys Acta; 2013 Oct; 1829(10):981-6. PubMed ID: 23684752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysine-Specific Demethylase 1 (LSD1)-Mediated Epigenetic Modification of Immunogenicity and Immunomodulatory Effects in Breast Cancers.
    Lee DY; Salahuddin T; Iqbal J
    Curr Oncol; 2023 Feb; 30(2):2127-2143. PubMed ID: 36826125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes.
    Cuyàs E; Gumuzio J; Verdura S; Brunet J; Bosch-Barrera J; Martin-Castillo B; Alarcón T; Encinar JA; Martin ÁG; Menendez JA
    Aging (Albany NY); 2020 Mar; 12(6):4794-4814. PubMed ID: 32191225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
    Battaglia S; Karasik E; Gillard B; Williams J; Winchester T; Moser MT; Smiraglia DJ; Foster BA
    Clin Epigenetics; 2017; 9():82. PubMed ID: 28811844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch.
    Tu WJ; McCuaig RD; Tan AHY; Hardy K; Seddiki N; Ali S; Dahlstrom JE; Bean EG; Dunn J; Forwood J; Tsimbalyuk S; Smith K; Yip D; Malik L; Prasanna T; Milburn P; Rao S
    Front Immunol; 2020; 11():1228. PubMed ID: 32612611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.
    Lim S; Janzer A; Becker A; Zimmer A; Schüle R; Buettner R; Kirfel J
    Carcinogenesis; 2010 Mar; 31(3):512-20. PubMed ID: 20042638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
    Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
    Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PRMT5-LSD1 axis confers Slug dual transcriptional activities and promotes breast cancer progression.
    Zhang J; Fan X; Zhou Y; Chen L; Rao H
    J Exp Clin Cancer Res; 2022 Jun; 41(1):191. PubMed ID: 35655230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
    Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
    Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.
    Huang Y; Vasilatos SN; Boric L; Shaw PG; Davidson NE
    Breast Cancer Res Treat; 2012 Feb; 131(3):777-89. PubMed ID: 21452019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting lysine-specific demethylase 1A inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis.
    Zhang X; Li LX; Yu C; Nath KA; Zhuang S; Li X
    FASEB J; 2022 Jan; 36(1):e22122. PubMed ID: 34958158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The histone demethylase LSD1 is required for estrogen-dependent S100A7 gene expression in human breast cancer cells.
    Yu SE; Jang YK
    Biochem Biophys Res Commun; 2012 Oct; 427(2):336-42. PubMed ID: 23000163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells.
    Wu Y; Wang Y; Yang XH; Kang T; Zhao Y; Wang C; Evers BM; Zhou BP
    Cell Rep; 2013 Oct; 5(1):224-36. PubMed ID: 24075993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.